ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Morel et al. [17] also reported the amplification of BCR/ABL1 in multiple double minutes (3-30) in a CML patient with imatinib resistance, but none of the patients from the present study contained such structures.